arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

SS Innovations International, Inc.

SSII
$1.92 ▼ -0.35 (-15.45%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
42 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

SS Innovations International, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $384.3M
Dividend Yield —
Revenue Growth 39.4% ↘
Op. Margin -16.3% ↗
ROIC -5.3% ↗
FCF / Share $-0.02 ↘
Trailing P/E —
Price / Book 7.2x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

42-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.94M
↑ +39.4% —
Net Income Profit after all expenses
$-2.66M
↓ -936.8% —
Operating Margin Operating profit as % of sales
-16.3%
↑ +50.3% 10th
FCF / Share Free cash flow per share
$-0.02
↓ -75.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
8
Returns
22
Financial Health ↑
21
Cash Quality ↑
84

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 42 quarters